QR Code

Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer

ABSTRACT Mutation of the tumor suppressor gene TP53 promotes ovarian cancer progression and therapeutic resistance. Whether mutant p53 (mtp53) regulates alternative splicing and how this regulation can be exploited for cancer therapy remain unclear. Here, small nuclear ribonucleoprotein D2 polypepti...

Full description

Saved in:
Main Authors: Wei Zhao, Qian Hao, Yu Gan, Jing Tong, Xiaodan Chen, Shuran Tan, Ruiwen Ruan, Yingdan Huang, Mingming Cao, Jun Deng, Tao Han, Getao Shi, Bo Gao, Yu Zhang, Xiang Zhou
Format: Artigo
Language:Inglês
Published: Wiley 2026-03-01
Series:Advanced Science
Subjects:
alternative splicing
engineered exosomes
p53
SNRPD2
targeted therapy
Online Access:https://doi.org/10.1002/advs.202513369
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items